Tel Aviv University team's scNET algorithm combines data on cells with protein 'social network' to cut 'high noise' and shed ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing ...

New methods for deriving macrophages from induced pluripotent stem cells are easier to scale and provide more clinically ...

Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicinesDesignation granted for warm autoimmune ...

Skin microbes do more than coexist—they shape immune responses, repair tissue, and influence gene expression across your ...

There is an urgent need for precision immunotherapy strategies that simultaneously target both tumor cells and immune cells ...

A new study published in Nature offers the most detailed map to date of how individual cell types in the brain change with ...

Strengthened Leadership and Expanded U.S. Presence Positions SynOx for Regulatory Filings and Commercialization of Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT) DUBLIN, Ireland and OXFORD, ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

Cardiac macrophages in newborn mice promoted heart cell proliferation after injury, offering a potential approach to ...

Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate ...